Product logins

Find logins to all Clarivate products below.


Physician-Dispensed Cosmeceuticals | Europe (Supplemental) | 2018 | Market Analysis

The European market for physician-dispensed cosmeceuticals will experience strong growth through 2026 due to the relatively high aesthetic consciousness in this region, an increasing number of physicians dispensing these products, and a growing use of physician-dispensed cosmeceuticals in combination with other aesthetic treatments.

This Medtech 360 Report provides key market metrics and high-level qualitative commentary for the physician-dispensed cosmeceutical market in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.

Related Medtech Insights Reports

Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Large-Joint Reconstructive Implants – Market Insights – Europe
The European large-joint reconstructive implant market is poised for long-term sustained growth, driven by the adoption of innovative technologies such as 3-D printed implants and smart implants,…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be driven primarily by the high incidence of gastric cancer and CRC in the region. Market growth will be supported by nationwide CRC and GI cancer…